Evidence map›Paper›PMID 42045195›Full record

ArticleNature communications2026

Proteasome alteration between epithelial and hematopoietic cells facilitates positive selection of CD8 T cells.

Mami Matsuda-Lennikov, Jamie-Jean De La Torre, Todd Snow, Jacqueline Battaile, Felix Kalle-Youngoue, Alison Jacques, Aya Ushio, Akihide Shimizu, Miho Shinzawa, Christian T Mayer and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mami Matsuda-LennikovThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jamie-Jean De La TorreThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Todd SnowThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0009-0002-9251-9119
Jacqueline BattaileThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0009-0003-1171-5714
Felix Kalle-YoungoueThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Alison JacquesThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Aya UshioThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Akihide ShimizuThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0009-0005-3067-8634
Miho ShinzawaLymphocyte Development Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7174-2464
Christian T MayerImmunomodulation Unit, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-0256-9650
Parirokh AwasthiMouse Modeling and Cryopreservation, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Raj ChariGenome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-2216-313X
Izumi OhigashiDivision of Experimental Immunology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.ORCID http://orcid.org/0000-0003-0017-6957
Shigeo MurataLaboratory of Protein Metabolism, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo, Japan.ORCID http://orcid.org/0000-0002-3177-3503
Yousuke TakahamaThymus Biology Section, Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. yousuke.takahama@nih.gov.ORCID http://orcid.org/0000-0002-4992-9174

Funding

Thymus biologyZIABC011806 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TAKAHAMA, YOUSUKE · 2018 to 2025
$13.5M
U.S. Department of Health & Human Services | National Institutes of Health (NIH) ZIA BC 011806
6 · The paper itself

Abstract

The thymoproteasome, a proteolytic complex uniquely expressed in cortical thymic epithelial cells (cTECs), governs the positive selection of CD8 T cells. It has been hypothesized that the thymoproteasome promotes CD8 T cell development by forging a sequential switch in proteasome species between cTECs and medullary antigen-presenting cells (APCs), which generates a stepwise difference in MHC-I-associated peptides between cTECs and medullary APCs, thereby sparing positively selected thymocytes from subsequent negative selection. In this study, we engineer mice ectopically expressing thymoproteasomes in various APCs including medullary TECs (mTECs), eliminating the proposed proteasome switch. Surprisingly, we find that the proteasome switch between cTECs and mTECs is dispensable for thymoproteasome-dependent CD8 T cell development. Instead, we find that ectopic thymoproteasomes in hematopoietic cells impair CD8 T cell development by hindering cortical positive selection. Our findings reveal that the proteasome difference between cTECs and hematopoietic cells in the thymic cortex facilitates thymoproteasome-dependent positive selection.

Indexed as

CD8-Positive T-LymphocytesEpithelial CellsHematopoietic Stem CellsProteasome Endopeptidase ComplexAnimalsAntigen-Presenting CellsCell DifferentiationFemaleMiceMice, Inbred C57BLMice, TransgenicThymocytesThymus GlandProteasome Endopeptidase Complex

Identifiers

PMID42045195
PMCPMC13324746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.